Patents Examined by Aaron J Kosar
  • Patent number: 11504410
    Abstract: Disclosed are means, compositions of matter, and protocols useful for neuroprotection and neuroregeneration. In one embodiment the invention provides administration of pterostilbene alone or in combination with other ingredients to induce neuroprotection and/or neuroregeneration. The invention teaches protection/regeneration in conditions associated with neurological inflammation and/or other congenital or acquired neurodegenerative diseases.
    Type: Grant
    Filed: July 28, 2021
    Date of Patent: November 22, 2022
    Assignee: Therapeutic Solutions International, Inc.
    Inventors: Thomas E. Ichim, Timothy G. Dixon, James Veltmeyer
  • Patent number: 11503840
    Abstract: Methods for decreasing harmful effects of blue light on skin are disclosed that include topically administering to a subject in need thereof a composition of an effective quantity of a purified, enzymatic hydrolysate of Theobroma cacao L. beans comprising peptides and saccharides having a molecular weight between 200 Da and 10 kDa in a physiologically acceptable medium. The hydrolysate of Theobroma cacao L. beans is present in the composition at a concentration from 0.001 to 20% with respect to the total weight of the composition. The composition can be a cosmetic composition.
    Type: Grant
    Filed: November 24, 2020
    Date of Patent: November 22, 2022
    Assignees: ISP INVESTMENTS LLC., JAFER ENTERPRISES R&D, S.L.
    Inventors: Corinne Coquet, Catherine Gondran, Isabelle Imbert, Joel Mantelin, Nouha Domloge, Sébastien Garnier, Jérémie Borsotto, Esmeralda Cicchetti, Florian Labarrade
  • Patent number: 11491203
    Abstract: Nutraceuticals Composition A (metabolic capacity enhancing compositions) comprises extraction or powder from White Kidney Bean, Green Tea, Green Coffee Bean, Garcinia Cambogia, Gymnema Sylvestre, L-Carnitine, Guarana, Ginger Root, Dandelion Root, Capsicum Cayenne, Licorice Root, Ascorbic Acid, d-Calcium Pantothenate, Pyridoxine HCl, Potassium Chloride, Magnesium Carbonate, and Chromium Yeast. Nutraceuticals Composition B (immunity capacity enhancing compositions) comprises extraction or powder from Grape Seed, Ginseng, Garlic, Rosehips, Green tea (Decaf), Astragalus, Beta Glucan Yeast, Reishi, Shitake, Maitake, Agricus blazei, Turkey Tail, Cordyceps, and Coenzyme CoQ10. The methods to make a synergistic Composition A and Composition B are formulated and are capable to provide a bioavailable dietary supplement and phytonutrients that can help modulate metabolism and enhance the human immune system.
    Type: Grant
    Filed: March 16, 2021
    Date of Patent: November 8, 2022
    Assignee: VIVA LIFE SCIENCE, INC.
    Inventors: Thuong Cao Do, Ping Yang
  • Patent number: 11484563
    Abstract: Compositions and methods for increasing stress response and improving health and slowing the aging process in a user. A composition includes one or more of a first group consisting of milk thistle, ashwagandha, green tea, bacopa monnieri, and turmeric. The composition includes one or more of a second group consisting of acetyl-L-carnitine, quercetin, lipoic acid, coenzyme Q10, cysteine, and grape. The composition includes one or more of a third group consisting of wasabi, theacrine, copper, nicacin, cysteine, and olive extract.
    Type: Grant
    Filed: January 13, 2021
    Date of Patent: November 1, 2022
    Assignee: LIFEVANTAGE CORPORATION
    Inventors: Brian Dixon, Christina Beer, Qiana Martinez
  • Patent number: 11471466
    Abstract: A method of forming a dietary supplement can include steps of creating a composition of matter comprising kava and CDP; and providing the composition of matter in a liquid or solid form. Providing the composition of matter can include filling a container with the composition of matter.
    Type: Grant
    Filed: April 10, 2020
    Date of Patent: October 18, 2022
    Inventor: James Peter Morrissette
  • Patent number: 11464761
    Abstract: A method of reducing anxiety in a non-human mammal by increasing brain serotonin levels, includes: down regulating in vivo levels of indigenous inflammatory cytokines in the nasal cavity of said non-human mammal by delivering an effective amount of an anti-inflammatory formula to said nasal cavity, which formula includes: at least one lipid-soluble antioxidant (which also functions as an anti-inflammatory agent) (the lipid-soluble antioxidant may be selected from the group consisting of alpha lipoic acid, aloe vera, omega 3 oil, N-acetylcysteine, cannabidiol, civet, oxytocin and combinations thereof); melatonin; tryptophan; and at least one essential oil. The most preferred antioxidant is N-acetylcysteine and the preferred essential oil is combination of chamomile, lavender and lemon oil.
    Type: Grant
    Filed: February 25, 2020
    Date of Patent: October 11, 2022
    Assignee: NORTH CELL PHARMACEUTICALS INC
    Inventor: Alain Martin
  • Patent number: 11464756
    Abstract: A dietary supplement or pharmaceutical formulation of Mecuna pruriens and/or L-DOPA, and 5-hydroxy-tryptophan (5-HTP) in an extended release carrier; and administration of the dietary supplement or pharmaceutical formulation to reduce stress or anxiety, improve mood, improve sleep, improve focus or concentration, reduce alcohol or drug cravings, or reduce sugar cravings.
    Type: Grant
    Filed: February 18, 2020
    Date of Patent: October 11, 2022
    Inventor: Jerry Darm
  • Patent number: 11458181
    Abstract: An herbal formula used for preparing a pharmaceutical composition for preventing and treating metabolic syndrome is provided. The herbal formula includes Rehmanniae radix preparata, Cornus officinalis, Dioscorea polystachya, Alisma plantago-aquatica, Paeonia suffruticosa, Poria cocos, Aconitum carmichaeli, and Cinnamomum cassia.
    Type: Grant
    Filed: May 22, 2020
    Date of Patent: October 4, 2022
    Inventor: Ying-Jih Chao Lee
  • Patent number: 11458180
    Abstract: An environmentally-friendly preparation method of a composition containing anti-inflammatory ingredients and use of the composition are provided. The method includes: S1. weighing a specified volume of water and adjusting the pH, adding Sophora flavescens roots, and subjecting a resulting mixture to extraction at a high temperature; S2. adjusting pH of an obtained solution in step S1, adding Glycyrrhiza inflata roots, and heating a resulting mixture to boiling for extraction; S3. adding Scutellaria baicalensis roots to an obtained boiling solution from the extraction in step S2, and subjecting a resulting mixture to extraction, filtration, and pH adjustment; S4. adding activated carbon to an obtained filtrate in step S3, and subjecting a resulting mixture to incubation and filtration; S5. adding a clarifying agent to an obtained filtrate in step S4, and subjecting a resulting mixture to standing and filtration; and S6. subjecting an obtained filtrate in step S5 to membrane separation.
    Type: Grant
    Filed: October 12, 2020
    Date of Patent: October 4, 2022
    Assignee: SHANGHAI JAKA BIOTECH CO., LTD.
    Inventors: Xinliang Wang, Yina Lu, Jun Tian
  • Patent number: 11452752
    Abstract: The present invention relates to a composition for antioxidation, anti-inflammation, or osteoclast differentiation inhibition and a composition for arthritis treatment, each of the compositions containing a fraction of a complex extract of Cynanchum wilfordii, Phlomis umbrosa, and Angelica gigas as an active ingredient. The compositions of the present invention can be effectively used for osteoclast differentiation inhibition, antioxidation, or anti-inflammation, and arthritis treatment.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: September 27, 2022
    Assignee: NATURAL ENDOTECH CO., LTD.
    Inventors: Jae Soo Kim, Kwon Taek Yi, Yong Wook Lee
  • Patent number: 11452744
    Abstract: A transplant product made from human amniotic fluid has a supernatant from filtered and centrifuged amniotic fluid, the amniotic fluid when recovered aseptically having a clear, translucent to slightly pink or tan color. The supernatant had been taken from the amniotic fluid which had been passed through a 170 to 260 micron blood filter, then centrifuged for 5 minutes or more at 400 g and thereafter the supernatant was separated from a pellet of debris, leaving the biochemical properties intact, wherein the supernatant is cryofrozen in sized cryovials having 0.25 to 2.0 ml of the supernatant at a temperature of ?65 degrees or less prior to use and the transplant products method of use. The transplant product contains cellular material, cell fragments, proteins and growth factors maintaining the biochemical properties and is non-immunogenic while having particles up to 170 microns being passable through a 30 gauge syringe for injection.
    Type: Grant
    Filed: October 15, 2020
    Date of Patent: September 27, 2022
    Assignee: Vivex Biologics Group, Inc.
    Inventors: Shabnam Namin, Gaëtan Jean-Robert Delcroix
  • Patent number: 11446348
    Abstract: Methods of manufacturing vegetable powders and/or vegetable compositions are described herein.
    Type: Grant
    Filed: December 31, 2018
    Date of Patent: September 20, 2022
    Inventor: Bilal Qizilbash
  • Patent number: 11446225
    Abstract: The present disclosure provides a mixture of sugar apple and rosemary extracts, optionally in combination with prickly ash extract, for use as skin care compositions.
    Type: Grant
    Filed: March 30, 2020
    Date of Patent: September 20, 2022
    Assignee: Unigen, Inc.
    Inventors: Lidia Alfaro Brownell, Min Chu, Brandon Corneliusen, Mei-Feng Hong, Ji-Hye Hwang, Eu-Jin Hyun, Qi Jia, Ping Jiao, Mi-Ran Kim, Bo-Su Lee, Young-Chul Lee, Jeong-Bum Nam, Mi-Sun Oh, Mesfin Yimam
  • Patent number: 11446330
    Abstract: Disclosed herein are compositions, methods, and systems for treating skin damage or signs of aging in a subject including obtaining whole blood from the subject, collecting platelet rich plasma (PRP) from the whole blood, forming a first topical formulation having the PRP, providing the first topical formulation to the subject for application to an area of skin damage on the subject, providing a second topical formulation to the subject having an activator such that when the second topical formulation is applied to the area of skin damage on top of the first formulation, the PRP is activated and growth factors are released into the area of skin damage. Systems and kits useful in performing the methods are also disclosed.
    Type: Grant
    Filed: February 25, 2021
    Date of Patent: September 20, 2022
    Assignee: AESTHETICS BIOMEDICAL, INC.
    Inventor: Shaun Wootten
  • Patent number: 11439681
    Abstract: The application discloses a traditional Chinese medicine composition for treating of type 2 diabetes, comprising the following raw materials: wild Descolor Cinquefoil Herb, wild Rhizoma imperatae, wild Root and Rhizome of Japanese Climbing Fern, Ginseng leaf (over 7 years), wild Rough Melic, wild Vitex negundo L., Morus alba L., green tea, wild auricularia, corn silk, dandelion root. The traditional Chinese medicine composition of the application is suitable for patients with type 2 diabetes and complications of type 2 diabetes, which has no adverse reactions and stable curative effect.
    Type: Grant
    Filed: December 13, 2020
    Date of Patent: September 13, 2022
    Inventor: Jinchang Ai
  • Patent number: 11419877
    Abstract: A method of forming a dietary supplement can include steps of creating a composition of matter comprising kava and GPC; and providing the composition of matter in a liquid or solid form. Providing the composition of matter can include filling a container with the composition of matter.
    Type: Grant
    Filed: April 17, 2020
    Date of Patent: August 23, 2022
    Inventor: James Peter Morrissette
  • Patent number: 11419828
    Abstract: The present invention is a hair care compositions, and more particularly to hair care compositions that contain a novel blend of natural ingredients which can be applied to the scalp and/or hair of a user for the treatment of scalp demodex which inturn helps to prevent hair loss and stimulates hair growth on male scalp. The composition includes at least one essential oil, a carrier oil and additives. One of the essential oils included is tea tree oil, the active ingredient of which is Terpinen-4-ol solution (T40).
    Type: Grant
    Filed: January 16, 2021
    Date of Patent: August 23, 2022
    Inventor: Ira Mark Stark
  • Patent number: 11400129
    Abstract: Method for modifying the essential fatty acid profile of eggs through low-dose nutritional supplementation based on plant extract rich in flavonoids in the plant extract. The present invention relates to a method for supplementing animals that produce eggs that are intended for consumption and/or reproduction using a very low dose of plant extract so as to naturally modulate the profile of essential fatty acid in the eggs produced. Said method consists of a step of supplementing the complete feed and/or the drinking water of the animals using a very low dose of the plant extract and makes it possible to significantly increase the proportion of at least one polyunsaturated fatty acid of the omega-3 family, particularly alpha-linolenic acid (ALA) and/or docosahexaenoic acid (DHA), in the eggs produced by these animals.
    Type: Grant
    Filed: May 7, 2019
    Date of Patent: August 2, 2022
    Assignee: NOR-FEED
    Inventors: Paul Engler, David Guilet
  • Patent number: 11400127
    Abstract: The present invention relates to a method for processing ginseng at an ultra high pressure, and more particularly, to a method for processing ginseng that is capable of processing the ginseng, which is immersed and packed, at an ultra high pressure. The method for processing ginseng includes the steps of: preparing washed ginseng; liquid-packaging the ginseng into a pouch; and treating the liquid-packaged ginseng with ultra-high pressure at a pressure of 550 to 600 MPa for 30 seconds to 2 minutes.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: August 2, 2022
    Assignee: NUTREX TECHNOLOGY CO., LTD.
    Inventors: Sung Han Kim, Jun Yong Jang, Sang Ho Lee, Sung Yul Yoo
  • Patent number: 11389498
    Abstract: The present invention relates to an anti-inflammatory composition and a composition for treatment of an inflammatory disease, both comprising a composite plant extract and, more particularly, to an anti-inflammatory composition comprising a composite plant extract including a Perilla frutescens extract and an Atractylodes macrocephala Koidzumi extract; a preparation method thereof; and a pharmaceutical composition comprising the composite extract for treatment of an inflammatory disease.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: July 19, 2022
    Assignee: Korea Atomic Energy Research Institute
    Inventors: Chang-Hyun Jin, Seung-Young Lee, Bo-Mi Nam, Yang-Kang So, Dong-Sub Kim, Si-Yong Kang, Jin-Baek Kim, Il-Yun Jeong